Prof. Hüseyin Engin is a medical oncologist with a strong clinical and professional background. He earned his medical oncology training at Hacettepe University Faculty of Medicine in 2003. He is currently affiliated with Acıbadem Health Group (2025). He is an active member of several professional organizations, including the Turkish Oncology Group Films Alumni Club (FAC), the European Society for Medical Oncology (ESMO), the Turkish Internal Medicine Specialty Society, and the Medical Oncology Society. His memberships reflect a commitment to ongoing collaboration, education, and excellence in cancer care.
Education
- 2003 Hacettepe University Faculty of Medicine Medical Oncology
- 1999 Hacettepe University Faculty of Medicine Internal Medicine
- 1994 Hacettepe University Faculty of Medicine
Experience
- 2025 Acibadem Health Group
- 2021 Şişli Hamidiye Etfal Training and Research Hospital / Prof. Dr.
- 2012 – 2021 Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Prof. Dr.
- 2006 – 2012 Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Assoc. Dr.
- 2004 – 2006 Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Asst. Assoc. Dr.
- 2004 Private Zonguldak A Medical Center, Zonguldak / Specialist Doctor
- 2003 Burhan Nalbantoğlu State Hospital, Nicosia, TRNC / Specialist Doctor
- 1999 – 2003 Hacettepe University Faculty of Medicine / Department of Internal Medicine / Division of Medical Oncology / Assistant
- 1999 – 2003 Tumor Biology and Immunology MSc Degree Program, Hacettepe University Oncology Institute, Division of Basic Oncology / Special Student
- 1994 – 1999 Hacettepe University Faculty of Medicine, Department of Internal Medicine / Assoc. Assist. Dr.
Memberships
- Turkish Oncology Group Flims Alumni Club (FAC)
- ESMO (European Society for Medical Oncology)
- Turkish Internal Medicine Specialty Society
- Medical Oncology Society
Publications
- Intraoperative Ultrasonography-Guided Surgery; An effective modality for breast conservation after neo-adjuvant ehemotherapy
Breast Journal. 2020;26:1680-1687 Taşdöven İ, Çakmak GK, Emre AU, Engin H. Bahadır B, Bakkal BH, Güllüoğlu MB. - Serum Sulphate Levels in Hemodialysis Patients
Int J Nephrol. 2019 Dec 1;2019:1063514. doi: 10.1155/2019/1063514. eCollection 2019 Yildirim I, Hur E, Magden K, İlikhan S, Engin H, Can M, Yıldız G, Özer İ. - Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospeetive analysis
Urun Y. J BUON. 2018 Dec;23(7): 116-121. Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N, - The effects of zoledronic acid on ECG: a prospeetive study on patients with bone metastatic cancer
Clin Cases Miner Bone Metab. 2017 Jan-Apr; 14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30. Demirtas D, Bilir C, Demirtas AO, Engin H. - Efficacv of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status
Curr Oncol. 2017 Jun;24(3):el99-e204. doi: 10.3747/co.24.3486. Epub 2017 Jun 27. Bilir C, Durak S, Kızılkaya B, Hacıbekiroglu I, Nayır E, Engin H. - Prognostic value of total lesion glycolysis in stage IIIB/IV nonesmall cell lung cancer.
Journal of Oncological Sciences 3 (2017) 107-11 Yusufoglu B, Bilir C, Engin H. - A Study on the Relationship Between Leptin and Leptin Receptor Gene Variants and Colorectal Cancer.
Muğla Sıtkı Koçman University Medical Journal. 2017;4(1): 10-14. Korkmaz N, Kimyon AS, Ermiş E, Edgünlü T, Arpacı E, Engin H. Karakaş Çelik S. - Using Interferon Alpha Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Celi Carcinoma: A Turkish Oncology Group (TOG) Study
Clin Genitourin Cancer. 2016 Aug; 14(4):e347-53. Artaç M, Çoşkun HŞ, Korkmaz L, Koçer M, Turhal IMS, Engin H. Dede İ, Paydaş S, Öksüzoğlu B, Bozcuk H, Demirkazık A. - 10. Red Celi Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous Thromboembolism
Indian J Hematol Blood Transfus. 2016 Dec;32(4):481-487. Ertop S, Bilici M, Engin H, Buyukuysal C, Arslaner M, Toka B, Tekin - Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer
Oncol Lett. 2015 Jun;9(6):2819-2824. Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F, Bayraktaroglu T.
